Clinical trial
Long-Term Study of IGE025 in Moderate to Severe Bronchial Asthma
NCT00219323 is registered in ClinicalTrials.gov with Novartis as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Long-Term Study of IGE025 in Moderate to Severe Bronchial Asthma
- Lead sponsor
- Novartis
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- November 30, 2003
- Completion date
- March 31, 2006
- Enrollment
- 133 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.